Trials / Recruiting
RecruitingNCT04904146
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Lund University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile. | The study aims to perform systematic translational sampling of each patient from study start until end-of-study, or at longest for a three year period for each patient. Treatment will be performed according to clinical routine. |
Timeline
- Start date
- 2021-04-02
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2021-05-27
- Last updated
- 2025-03-10
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04904146. Inclusion in this directory is not an endorsement.